Research Spotlight: Disparities in the Initiation of Guideline-Recommended Diabetes Medications
Short description of the study goes here. And be sure to update the link below to the new spotlight page you just created.
Department of Medicine
Williams Laboratory: Winfred Williams, MD
The Winfred Williams Laboratory at Massachusetts General Hospital studies the genetic basis of chronic allograft nephropathy.
Winfred Williams, MD
Assistant Professor of Medicine
Associate Chief, Division of Nephrology
CPZN 6.808
185 Cambridge Street
Boston,
MA
02114
Phone: 617-643-3289
Fax: 617-724-1122
Email: wwwilliams@partners.org
About the Lab
Dr. Williams studies the genetic basis of chronic allograft nephropathy as an Associate Member of the Broad Institute. Human genome sequencing revealed that the entire autosomal genes may deleted, with some of these gene-deletion alleles being sufficiently common. Because the immune system of an individual with a homozygous gene deletion may not be tolerant to a "foreign" antigen from a donor, such genomic variations may contribute to risk of chronic rejection and alloimmune disease. Studies are being conducted to determine whether donor-recipient mismatch for homozygous gene deletions increases the risk of kidney rejection after transplantation.
Primary Researcher
-
![]()
- Nephrology
- Department of Medicine
About the Nephrology Division
The Division of Nephrology at Massachusetts General Hospital is a leading provider of services for patients with kidney disease, including diagnosis and management of kidney diseases and medical management of renal transplantation.